⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

Official Title: A Phase II, Randomized, Open-label Platform Trial Utilizing a Master Protocol to Study Novel Regimens Versus Standard of Care Treatment in NSCLC Participants

Study ID: NCT03739710

Conditions

Neoplasms

Study Description

Brief Summary: This study will compare the clinical activity of novel regimens (in combination or as single agents) to SoC in participants with relapsed/refractory advanced NSCLC. The study will be conducted in two parts. Part 1 is an open-label, optional, non-randomized part based on safety and pharmacokinetics/pharmacodynamics (PK/PD) evaluation intended to generate additional data to qualify novel regimens for the randomized study. Part 2 is a randomized, Phase II open-label part comparing the efficacy and safety of these novel regimens with SoC. Drug name mentioned as GSK4428859A (belrestotug) and EOS884448 are interchangeable for the same compound and will be referred to as GSK4428859A/EOS884448/belrestotug.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

GSK Investigational Site, Los Angeles, California, United States

GSK Investigational Site, Saint Louis, Missouri, United States

GSK Investigational Site, Bronx, New York, United States

GSK Investigational Site, Bronx, New York, United States

GSK Investigational Site, Pinehurst, North Carolina, United States

GSK Investigational Site, Chattanooga, Tennessee, United States

GSK Investigational Site, Nashville, Tennessee, United States

GSK Investigational Site, Dallas, Texas, United States

GSK Investigational Site, Edmonton, Alberta, Canada

GSK Investigational Site, Brampton, Ontario, Canada

GSK Investigational Site, Toronto, Ontario, Canada

GSK Investigational Site, Bordeaux Cedex, , France

GSK Investigational Site, Caen Cedex 9, , France

GSK Investigational Site, Nantes cedex 1, , France

GSK Investigational Site, Paris Cedex 05, , France

GSK Investigational Site, Paris, , France

GSK Investigational Site, Villejuif Cedex, , France

GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany

GSK Investigational Site, Gauting, Bayern, Germany

GSK Investigational Site, Immenhausen, Hessen, Germany

GSK Investigational Site, Kassel, Hessen, Germany

GSK Investigational Site, Leipzig, Sachsen, Germany

GSK Investigational Site, Grosshansdorf, Schleswig-Holstein, Germany

GSK Investigational Site, Berlin, , Germany

GSK Investigational Site, Napoli, Campania, Italy

GSK Investigational Site, Meldola (FC), Emilia-Romagna, Italy

GSK Investigational Site, Ravenna, Emilia-Romagna, Italy

GSK Investigational Site, Milano, Lombardia, Italy

GSK Investigational Site, Orbassano (TO), Piemonte, Italy

GSK Investigational Site, Siena, Toscana, Italy

GSK Investigational Site, Cheongju-si, Chungcheongbuk-do, , Korea, Republic of

GSK Investigational Site, Gyeonggi-do, , Korea, Republic of

GSK Investigational Site, Seongnam, , Korea, Republic of

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Amsterdam, , Netherlands

GSK Investigational Site, Maastricht, , Netherlands

GSK Investigational Site, Lodz, , Poland

GSK Investigational Site, Poznan, , Poland

GSK Investigational Site, Warszawa, , Poland

GSK Investigational Site, Bucharest, , Romania

GSK Investigational Site, Craiova, , Romania

GSK Investigational Site, Floresti, , Romania

GSK Investigational Site, Otopeni, , Romania

GSK Investigational Site, Timisoara, , Romania

GSK Investigational Site, Chelyabinsk, , Russian Federation

GSK Investigational Site, Saint-Petersburg, , Russian Federation

GSK Investigational Site, Saint-Petersburg, , Russian Federation

GSK Investigational Site, Badajoz, , Spain

GSK Investigational Site, Barcelona, , Spain

GSK Investigational Site, Barcelona, , Spain

GSK Investigational Site, Madrid, , Spain

GSK Investigational Site, Madrid, , Spain

GSK Investigational Site, Madrid, , Spain

GSK Investigational Site, Málaga, , Spain

GSK Investigational Site, Santander, , Spain

GSK Investigational Site, Sevilla, , Spain

GSK Investigational Site, Solna, , Sweden

GSK Investigational Site, Uppsala, , Sweden

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: